• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India.印度射血分数降低的稳定性急性失代偿性心力衰竭管理文件的共识与制定。
Indian Heart J. 2020 Nov-Dec;72(6):477-481. doi: 10.1016/j.ihj.2020.09.007. Epub 2020 Sep 18.
2
One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India.急性心力衰竭患者的一年死亡率及再入院情况:来自印度喀拉拉邦特里凡得琅心力衰竭登记处的数据。
Am Heart J. 2017 Jul;189:193-199. doi: 10.1016/j.ahj.2017.03.019. Epub 2017 Apr 2.
3
Clinical profile and 90 day outcomes of 10 851 heart failure patients across India: National Heart Failure Registry.印度 10851 例心力衰竭患者的临床特征和 90 天结局:国家心力衰竭注册研究。
ESC Heart Fail. 2022 Dec;9(6):3898-3908. doi: 10.1002/ehf2.14096. Epub 2022 Aug 10.
4
Acute decompensated heart failure in a North Indian community hospital: Demographics, clinical characteristics, comorbidities and adherence to therapy.印度北部社区医院急性失代偿性心力衰竭:人口统计学、临床特征、合并症和治疗依从性。
Indian Heart J. 2020 Jan-Feb;72(1):27-31. doi: 10.1016/j.ihj.2020.03.004. Epub 2020 Mar 24.
5
Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.出院前优化指南指导的药物治疗对射血分数降低的心力衰竭住院患者死亡率和心力衰竭再入院的影响。
Am J Cardiol. 2018 Apr 15;121(8):969-974. doi: 10.1016/j.amjcard.2018.01.006. Epub 2018 Feb 21.
6
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.射血分数保留的心力衰竭失代偿期中心肌肌钙蛋白升高的相关因素及其预后意义:美国心脏协会 Get With The Guidelines-Heart Failure 项目的研究结果。
JAMA Cardiol. 2017 Feb 1;2(2):136-145. doi: 10.1001/jamacardio.2016.4726.
7
Improving quality of care in patients with decompensated acute heart failure using a discharge checklist.使用出院清单改善失代偿性急性心力衰竭患者的护理质量。
Arch Cardiovasc Dis. 2019 Aug-Sep;112(8-9):494-501. doi: 10.1016/j.acvd.2019.05.003. Epub 2019 Jul 25.
8
Presentation, Management, and In-Hospital Outcomes of Patients with Acute Heart Failure in South India by Sex: A Secondary Analysis of a Prospective, Interrupted Time Series Study.印度南部急性心力衰竭患者的临床表现、治疗和院内结局的性别差异:一项前瞻性、间断时间序列研究的二次分析。
Glob Heart. 2021 Sep 27;16(1):63. doi: 10.5334/gh.1043. eCollection 2021.
9
Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline-directed medical therapy in heart failure with reduced ejection fraction.在斯库拉和卡律布狄斯之间航行:在射血分数降低的心力衰竭中实施指南指导的药物治疗的挑战和策略。
Eur J Heart Fail. 2021 Dec;23(12):1999-2007. doi: 10.1002/ejhf.2378. Epub 2021 Dec 13.
10
Predictors of mortality, strategies to reduce readmission, and economic impact of acute decompensated heart failure: Results of the Vellore Heart Failure Registry.急性失代偿性心力衰竭的死亡率预测因素、再入院策略和经济影响:Vellore 心力衰竭登记研究结果。
Indian Heart J. 2020 Jan-Feb;72(1):20-26. doi: 10.1016/j.ihj.2020.03.005. Epub 2020 Mar 24.

引用本文的文献

1
Optimizing Cardiovascular Outcomes With Bisoprolol: An Evidence-Based Perspective.从循证角度看比索洛尔对心血管结局的优化作用
Cureus. 2025 Aug 7;17(8):e89579. doi: 10.7759/cureus.89579. eCollection 2025 Aug.
2
Impact of discharge checklist on guideline-directed medical therapy and mid-term prognosis in heart failure.出院清单对心力衰竭指南指导的药物治疗和中期预后的影响。
Korean J Intern Med. 2024 Nov;39(6):945-956. doi: 10.3904/kjim.2024.088. Epub 2024 Oct 24.
3
ADDition of DAPAgliflozin, Sodium-Glucose Cotransporter-2 Inhibitor to Angiotensin Receptor Blocker-Neprilysin Inhibitors Non-Responders in Patient with Refractory Heart Failure with Reduced Ejection Fraction (ADD DAPA trial).达格列净、钠-葡萄糖共转运蛋白 2 抑制剂联合血管紧张素受体脑啡肽酶抑制剂治疗射血分数降低的难治性心力衰竭患者(ADD DAPA 试验)。
Indian Heart J. 2021 Sep-Oct;73(5):605-611. doi: 10.1016/j.ihj.2021.07.005. Epub 2021 Jul 19.

本文引用的文献

1
Clinical profile and one-year survival of patients with heart failure with reduced ejection fraction: The largest report from India.射血分数降低的心力衰竭患者的临床特征及一年生存率:来自印度的最大规模报告。
Indian Heart J. 2019 May-Jun;71(3):242-248. doi: 10.1016/j.ihj.2019.07.008. Epub 2019 Aug 7.
2
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight Committee.2019年美国心脏病学会解决方案集监督委员会关于心力衰竭住院患者风险评估、管理及临床进程的专家共识决策路径报告
J Am Coll Cardiol. 2019 Oct 15;74(15):1966-2011. doi: 10.1016/j.jacc.2019.08.001. Epub 2019 Sep 13.
3
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.在院或出院早期血流动力学稳定的心力衰竭患者中起始沙库巴曲缬沙坦治疗:随机 TRANSITION 研究的主要结果。
Eur J Heart Fail. 2019 Aug;21(8):998-1007. doi: 10.1002/ejhf.1498. Epub 2019 May 27.
4
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.2019 年心力衰竭临床实践更新:药物治疗、程序、设备和患者管理。欧洲心脏病学会心力衰竭协会专家共识会议报告。
Eur J Heart Fail. 2019 Oct;21(10):1169-1186. doi: 10.1002/ejhf.1531. Epub 2019 Aug 30.
5
Supporting the Management of Patients with Heart Failure within Asia-Pacific, Middle East, and African Countries: A Toolbox for Healthcare Providers.支持亚太地区、中东和非洲国家心力衰竭患者的管理:医疗服务提供者工具箱
Cardiology. 2019;142 Suppl 1:1-10. doi: 10.1159/000496663. Epub 2019 Apr 4.
6
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.血管紧张素-脑啡肽酶抑制剂在急性失代偿性心力衰竭中的应用。
N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.
7
CSI position statement on management of heart failure in India.印度心脏病学会关于心力衰竭管理的立场声明。
Indian Heart J. 2018 Jul;70 Suppl 1(Suppl 1):S1-S72. doi: 10.1016/j.ihj.2018.05.003. Epub 2018 Jun 8.
8
In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry.印度南部心力衰竭患者的住院和三年结局:特里凡得琅心力衰竭注册研究。
J Card Fail. 2018 Dec;24(12):842-848. doi: 10.1016/j.cardfail.2018.05.007. Epub 2018 Jun 7.
9
Management protocols for chronic heart failure in India.印度慢性心力衰竭的管理方案。
Indian Heart J. 2018 Jan-Feb;70(1):105-127. doi: 10.1016/j.ihj.2017.11.015. Epub 2017 Nov 22.
10
Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure.持续的高血尿素氮水平与急性心力衰竭患者心血管事件风险增加相关。
ESC Heart Fail. 2017 Nov;4(4):545-553. doi: 10.1002/ehf2.12188. Epub 2017 Jun 27.

印度射血分数降低的稳定性急性失代偿性心力衰竭管理文件的共识与制定。

Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India.

机构信息

Dept of Cardiology, Batra Hospital and Research Centre, 1, Mehrauli Badarpur Rd, Tughlakabad Institutional Area, New Delhi, India.

Dept of Cardiology, CMRI Hospitals, 7/2 Diamond Harbour Road, Kolkata, West Bengal, India.

出版信息

Indian Heart J. 2020 Nov-Dec;72(6):477-481. doi: 10.1016/j.ihj.2020.09.007. Epub 2020 Sep 18.

DOI:10.1016/j.ihj.2020.09.007
PMID:33357634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7772598/
Abstract

AIM

Ensuring adherence to guideline-directed medical therapy (GDMT) is an effective strategy to reduce mortality and readmission rates for heart failure (HF). Use of a checklist is one of the best tools to ensure GDMT. The aim was to develop a consensus document with a robust checklist for stabilized acute decompensated HF patients with reduced ejection fraction. While there are multiple checklists available, an India-specific checklist that is easy to fill and validated by regional and national subject matter experts (SMEs) is required.

METHODOLOGY

A total of 25 Cardiology SMEs who consented to participate from India discussed data from literature, current evidence, international guidelines and practical experiences in two national and four regional meetings.

RESULTS

Recommendations included HF management, treatment optimization, and patient education. The checklist should be filled at four time points- (a) transition from intensive care unit to ward, (b) at discharge, (c) 1st follow-up and (d) subsequent follow-up. The checklist is the responsibility of the consultant or the treating physician which can be delegated to a junior resident or a trained HF nurse.

CONCLUSION

This checklist will ensure GDMT, simplify transition of care and can be used by all doctors across India. Institutions, associations, and societies should recommend this checklist for adaptability in public and private hospital. Hospital administrations should roll out policy for adoption of checklist by ensuring patient files have the checklist at the time of discharge and encourage practice of filling it diligently during follow-up visits.

摘要

目的

遵循指南指导的医学治疗(GDMT)是降低心力衰竭(HF)死亡率和再入院率的有效策略。使用清单是确保 GDMT 的最佳工具之一。目的是为射血分数降低的稳定急性失代偿性 HF 患者制定一份共识文件,其中包含一个强大的检查表。虽然有多种清单可用,但需要一份易于填写且经过地区和国家主题专家(SME)验证的印度特定清单。

方法

共有 25 名来自印度的心脏病学 SME 同意参与,他们在两次国家会议和四次地区会议上讨论了文献、当前证据、国际指南和实践经验中的数据。

结果

建议包括 HF 管理、治疗优化和患者教育。检查表应在四个时间点填写-(a)从重症监护病房到病房的过渡,(b)出院时,(c)第 1 次随访和(d)随后的随访。检查表由顾问或主治医生负责,可以委派给初级住院医师或经过培训的 HF 护士。

结论

这份检查表将确保 GDMT,简化护理过渡,可以被印度各地的所有医生使用。机构、协会和学会应推荐这份检查表,以适应公立医院和私立医院。医院管理部门应推出采用检查表的政策,确保患者出院时的病历中有检查表,并鼓励在随访期间认真填写。